We are live on ! Find out more
AIP

ARS Investment Partners Portfolio holdings

AUM $2.29B
1-Year Est. Return 113.95%
This Fund
S&P 500
This Quarter Est. Return
+15.21%
1 Year Est. Return
+113.95%
3 Year Est. Return
+260.1%
5 Year Est. Return
+332.48%
10 Year Est. Return
+1,634.5%
AUM
$1B
AUM Growth
+$101M
Cap. Flow
-$2.58M
Cap. Flow %
-0.26%
Top 10 Hldgs %
42.76%
Holding
174
New
17
Increased
36
Reduced
67
Closed
13

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$13.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$11.4M
3
GE icon
GE Aerospace
GE
+$7.65M
4
NVDA icon
NVIDIA
NVDA
+$3.25M
5
PWR icon
Quanta Services
PWR
+$1.05M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.9M
2
SKT icon
Tanger
SKT
+$4.65M
3
LILAK icon
Liberty Latin America Class C
LILAK
+$4.55M
4
MLM icon
Martin Marietta Materials
MLM
+$4.26M
5
ASND icon
Ascendis Pharma A/S
ASND
+$3.96M

Sector Composition

Rank Sector Weight
1 Technology 23.8%
2 Materials 17.12%
3 Healthcare 13.69%
4 Industrials 12.69%
5 Communication Services 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$65.7M 6.54%
382,948
-60,175
-14% -$10.9M
MU icon
2
Micron Technology
MU
$1.04T
$48.2M 4.81%
409,083
-1,023
-0.2% -$92.6K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.91T
$47.1M 4.69%
312,072
-1,672
-0.5% -$239K
LRCX icon
4
Lam Research
LRCX
$382B
$46.9M 4.68%
482,940
-38,100
-7% -$3.35M
FCX icon
5
Freeport-McMoran
FCX
$90B
$44.3M 4.41%
942,023
-1,519
-0.2% -$61.3K
ASND icon
6
Ascendis Pharma A/S
ASND
$16.7B
$38.5M 3.84%
254,967
-27,777
-10% -$3.96M
AMZN icon
7
Amazon
AMZN
$2.5T
$35.9M 3.57%
198,799
-1,217
-0.6% -$203K
CLF icon
8
Cleveland-Cliffs
CLF
$6.81B
$35.8M 3.57%
1,573,506
+30,409
+2% +$603K
BHVN icon
9
Biohaven
BHVN
$2.16B
$34.8M 3.47%
636,371
+2,407
+0.4% +$119K
NVDA icon
10
NVIDIA
NVDA
$5.01T
$31.9M 3.18%
353,090
+44,840
+15% +$3.25M
CRH icon
11
CRH
CRH
$66.7B
$30.2M 3.01%
350,354
+182,207
+108% +$13.9M
AVGO icon
12
Broadcom
AVGO
$1.82T
$30M 2.99%
226,550
+660
+0.3% +$81.8K
MPC icon
13
Marathon Petroleum
MPC
$90.3B
$24.7M 2.46%
122,621
+606
+0.5% +$104K
KTOS icon
14
Kratos Defense & Security Solutions
KTOS
$8.88B
$22.9M 2.28%
1,244,754
-118,728
-9% -$2.16M
RTX icon
15
RTX Corp
RTX
$287B
$22.7M 2.26%
232,780
+194
+0.1% +$17.5K
SPY icon
16
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$22.4M 2.23%
42,771
-1,007
-2% -$501K
MLM icon
17
Martin Marietta Materials
MLM
$33.6B
$21.7M 2.17%
35,408
-7,801
-18% -$4.26M
AJG icon
18
Arthur J. Gallagher & Co
AJG
$63.7B
$20.9M 2.08%
83,599
-156
-0.2% -$37.5K
CMC icon
19
Commercial Metals
CMC
$7.63B
$19.3M 1.92%
327,906
-805
-0.2% -$42.6K
GEHC icon
20
GE HealthCare
GEHC
$27.6B
$16.8M 1.68%
185,023
-973
-0.5% -$81K
MRK icon
21
Merck
MRK
$324B
$16.2M 1.61%
122,692
-165
-0.1% -$20.3K
GM icon
22
General Motors
GM
$74.7B
$15.9M 1.59%
351,005
-1,628
-0.5% -$63.1K
MP icon
23
MP Materials
MP
$7.35B
$15.3M 1.53%
1,072,928
+3,565
+0.3% +$56.4K
LHX icon
24
L3Harris
LHX
$55.9B
$15.1M 1.5%
70,772
-238
-0.3% -$50K
ETN icon
25
Eaton
ETN
$157B
$15.1M 1.5%
48,135
+256
+0.5% +$70K
1
2 3 4 5

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
RA
RPOA Advisors Plano, Texas $2.29B AUM 11.74% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

ARS Investment Partners's Q1 2024 Portfolio in Review

As of Q1 2024, ARS Investment Partners held 174 positions worth $1B, up 11% from $902M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

ARS Investment Partners's Q1 2024 filing shows 17 new, 36 increased, 67 reduced and 13 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 12,006 shares worth $11.6M. The largest sale was Apple, an estimated $10.9M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Materials and Healthcare.

  • ARS Investment Partners's largest Q1 2024 buy was Regeneron Pharmaceuticals: 12,006 shares worth $11.6M.
  • ARS Investment Partners added most to CRH in Q1 2024, an estimated $13.9M increase.
  • ARS Investment Partners's biggest Q1 2024 reduction was Apple, cutting an estimated $10.9M.
  • ARS Investment Partners fully exited Tanger in Q1 2024, selling an estimated $4.65M.
  • ARS Investment Partners's ten largest holdings make up 43% of its $1B portfolio in Q1 2024.
  • ARS Investment Partners opened 17 new positions and closed 13 in Q1 2024.
  • ARS Investment Partners's portfolio value rose 11% quarter-over-quarter to $1B.

Based on ARS Investment Partners's 13F filing for Q1 2024, filed 2 May 2024.